Details for New Drug Application (NDA): 079003
✉ Email this page to a colleague
The generic ingredient in IBANDRONATE SODIUM is ibandronate sodium. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the ibandronate sodium profile page.
Summary for 079003
| Tradename: | IBANDRONATE SODIUM |
| Applicant: | Watson Labs Teva |
| Ingredient: | ibandronate sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
| Approval Date: | Mar 20, 2012 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
